Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$10.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.19M |
| 3 |
NXP Semiconductors
NXPI
|
+$7.89M |
| 4 |
Occidental Petroleum
OXY
|
+$7.78M |
| 5 |
FedEx
FDX
|
+$6.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$37.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$21.8M |
| 3 |
Amazon
AMZN
|
+$17.7M |
| 4 |
Quanta Services
PWR
|
+$15.2M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$13.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.25% |
| 2 | Consumer Discretionary | 15.93% |
| 3 | Industrials | 14.92% |
| 4 | Healthcare | 12.91% |
| 5 | Consumer Staples | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Enova International
ENVA
$6.05B
| $222K | 0.01% |
+6,264
| New | +$188K |
|
927
NovoCure
NVCR
$1.99B
| $220K | 0.01% |
+1,662
| New | +$263K |
|
928
Sinclair Inc
SBGI
$1.04B
| $219K | 0.01% |
+7,479
| New | +$249K |
|
929
Teleflex
TFX
$5.88B
| $219K | 0.01% |
+526
| New | +$211K |
|
930
Steel Dynamics
STLD
$32.8B
| $217K | 0.01% |
4,278
-6,955
| -62% | -$293K |
|
|
EFOR
931
Everforth Inc
EFOR
$1.34B
| $213K | 0.01% |
+2,227
| New | +$206K |
|
932
Fabrinet
FN
$15.6B
| $213K | 0.01% |
+2,359
| New | +$204K |
|
933
lululemon athletica
LULU
$13.7B
| $213K | 0.01% |
695
-277
| -28% | -$90.9K |
|
934
Curtiss-Wright
CW
$23.5B
| $212K | 0.01% |
1,791
-3,167
| -64% | -$366K |
|
935
Henry Schein
HSIC
$9.86B
| $212K | 0.01% |
+3,058
| New | +$207K |
|
936
ICF International
ICFI
$1.6B
| $212K | 0.01% |
+2,426
| New | +$203K |
|
937
Western Alliance Bancorporation
WAL
$8.69B
| $212K | 0.01% |
+2,245
| New | +$186K |
|
|
EGOV
938
DELISTED
NIC Inc
EGOV
| $211K | 0.01% |
6,206
-5,991
| -49% | -$189K |
|
939
Keurig Dr Pepper
KDP
$43.6B
| $210K | 0.01% |
6,121
-3,288
| -35% | -$107K |
|
940
Belden
BDC
$4.79B
| $208K | 0.01% |
4,681
-3,383
| -42% | -$154K |
|
|
HOUS
941
DELISTED
Anywhere Real Estate
HOUS
| $208K | 0.01% |
+13,757
| New | +$219K |
|
942
Veeco
VECO
$2.93B
| $208K | 0.01% |
+10,034
| New | +$209K |
|
943
Hercules Capital
HTGC
$3.21B
| $207K | 0.01% |
12,936
-81
| -0.6% | -$1.26K |
|
944
Apollo Global Management
APO
$78.4B
| $206K | 0.01% |
+4,391
| New | +$214K |
|
945
Ironwood Pharmaceuticals
IRWD
$709M
| $206K | 0.01% |
18,437
+1,875
| +11% | +$19.8K |
|
946
American Express
AXP
$227B
| $205K | 0.01% |
1,449
-1,937
| -57% | -$256K |
|
|
ATH
947
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $204K | 0.01% |
4,051
-1,930
| -32% | -$89.6K |
|
948
CAE Inc
CAE
$8.02B
| $203K | 0.01% |
7,120
-7,138
| -50% | -$190K |
|
949
Fortis
FTS
$28B
| $203K | 0.01% |
+4,679
| New | +$192K |
|
|
TELL
950
DELISTED
Tellurian Inc.
TELL
| $203K | 0.01% |
86,696
+44,412
| +105% | +$121K |
|
Similar funds
Joel Greenblatt's Q1 2021 Portfolio in Review
As of Q1 2021, Joel Greenblatt held 1,161 positions worth $2.24B, down 26% from $3.02B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Joel Greenblatt withdrew a net $1.04B in Q1 2021, closing 182 positions and reducing 614 holdings. Its most notable exit was Novavax, an estimated $9.66M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Joel Greenblatt opened a new position in Becton Dickinson worth $5.64M.
- Joel Greenblatt's largest Q1 2021 buy was Becton Dickinson: 23,757 shares worth $5.64M.
- Joel Greenblatt added most to Dominion Energy in Q1 2021, an estimated $10.5M increase.
- Joel Greenblatt's biggest Q1 2021 reduction was Apple, cutting an estimated $37.2M.
- Joel Greenblatt fully exited Novavax in Q1 2021, selling an estimated $9.66M.
- Joel Greenblatt's ten largest holdings make up 12% of its $2.24B portfolio in Q1 2021.
- Joel Greenblatt opened 177 new positions and closed 182 in Q1 2021.
- Joel Greenblatt's portfolio value fell 26% quarter-over-quarter to $2.24B.
Based on Gotham Asset Management's 13F filing for Q1 2021, filed 17 May 2021.